Skip to main content
Top
Published in: Journal of Polymer Research 8/2014

01-08-2014 | Original Paper

Preparation and characterization of novel derivatives of chitosan and trimethyl chitosan conjugated with dipeptides and vitamin B12 as candidates for oral delivery of insulin

Authors: Nersi Jafary Omid, Niloofar Babanejad, Hossein Amini, Mohsen Amini, Morteza Rafiee Tehrani, Farid Dorkoosh

Published in: Journal of Polymer Research | Issue 8/2014

Log in

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

Chitosan and its derivatives are widely used in drug delivery systems due to their bio-degradebility, bio-compatibility and absorption enhancing properties. Many peptide and protein derived therapeutics cannot be administered through oral rout because of the proteolytic condition of gastro-intestinal tract and their low bio-availability. Insulin is a peptide drug which is widely used in diabetics as repeated daily injection. Due to the fact that there are receptors for didpeptides and vitamine B12 in small intestine, in this research work novel derivatives of chitosan and trimethyl chitosan conjugated with glycyl-glycine, alanyl-alaninie and vitamine B12 were synthesized and characterized. The structure of conjugates as well as substitution of different functional groups was confirmed by different instrumental analytical methods such as Fourier transform infrared, magnetic resonance, and X-ray diffraction spectroscopy. Nano-particles of aforementioned loaded with insulin were prepared and their size, surface electrical charge and morphology characterized and their release profile were studied. The results are promising and reveal that these new chitosan and trimethyl chitosan derivatives are potential vehicles for protein and peptide drug molecules.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Literature
1.
go back to reference Guyton AC (1991) Textbook of medical physiology, 8th edn. W. B. Saunders, Philadelphia Guyton AC (1991) Textbook of medical physiology, 8th edn. W. B. Saunders, Philadelphia
2.
go back to reference Rawn JD (1989) Biochemistry. Carolina Neil Patterson Publishers, Burlington Rawn JD (1989) Biochemistry. Carolina Neil Patterson Publishers, Burlington
4.
7.
go back to reference Jellinger PS (2007) Metabolic consequences of hyperglycemia and insulin resistance. Clin Cornerstone 8(Supplement 7):S30–S42CrossRef Jellinger PS (2007) Metabolic consequences of hyperglycemia and insulin resistance. Clin Cornerstone 8(Supplement 7):S30–S42CrossRef
9.
go back to reference Michael G, inventor Emisphere Technologies, Inc., assignee (2008) Night-time oral insulin therapy patent 7,384,914 Michael G, inventor Emisphere Technologies, Inc., assignee (2008) Night-time oral insulin therapy patent 7,384,914
10.
go back to reference Hamman JH, Enslin GM, Kotz AF (2005) Oral delivery of peptide drugs. BioDrugs 19(3):165–177CrossRef Hamman JH, Enslin GM, Kotz AF (2005) Oral delivery of peptide drugs. BioDrugs 19(3):165–177CrossRef
13.
go back to reference Owens DR, Zinman B, Bolli G (2003) Alternative routes of insulin delivery. Diabet Med 20:886–898CrossRef Owens DR, Zinman B, Bolli G (2003) Alternative routes of insulin delivery. Diabet Med 20:886–898CrossRef
14.
go back to reference Lassmann-Vague V, Raccah D (2006) Alternatives routes of insulin delivery. Diabetes Metab 32:513–522CrossRef Lassmann-Vague V, Raccah D (2006) Alternatives routes of insulin delivery. Diabetes Metab 32:513–522CrossRef
15.
go back to reference Ekwuribe NN, inventor Protein Delivery, Inc., assignee (1994) Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same and method of making and using the same patent 5359030 Ekwuribe NN, inventor Protein Delivery, Inc., assignee (1994) Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same and method of making and using the same patent 5359030
16.
go back to reference Ekwuribe NN, inventor Protein Delivery, Inc., assignee (1995) Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same and method of making and using the same patent 5438040 Ekwuribe NN, inventor Protein Delivery, Inc., assignee (1995) Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same and method of making and using the same patent 5438040
17.
go back to reference Ekwuribe NN, inventor Protein Deliver, Inc., assignee (1997) Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same and method of making and using the same patent 5681811 Ekwuribe NN, inventor Protein Deliver, Inc., assignee (1997) Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same and method of making and using the same patent 5681811
18.
go back to reference Ekwuribe NN, Ramaswamy M, Radhakrishnan B, Allaudeen HS, inventors; Protein Delivery, Inc., assignee (2001) Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugated-stabilized therapeutic agents such as insulin patent 6191105 Ekwuribe NN, Ramaswamy M, Radhakrishnan B, Allaudeen HS, inventors; Protein Delivery, Inc., assignee (2001) Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugated-stabilized therapeutic agents such as insulin patent 6191105
19.
go back to reference Arbit E, Abbas R, Michael G, Woods TC, Dinh S, Wong V, inventors; Emisphere Technologies, Inc., assignee (2008) Oral insulin therapy patent 7429564 Arbit E, Abbas R, Michael G, Woods TC, Dinh S, Wong V, inventors; Emisphere Technologies, Inc., assignee (2008) Oral insulin therapy patent 7429564
20.
go back to reference Dorkoosh FA, Coos Verhoef J, Ambagts MHC, Rafiee-Tehrani M, Borchard G, Junginger HE (2002) Peroral delivery systems based on superporous hydrogel polymers: release characteristics for the peptide drugs buserelin, octreotide and insulin. Eur J Pharm Sci 15(5):433–439. doi:10.1016/S0928-0987(02)00028-3 CrossRef Dorkoosh FA, Coos Verhoef J, Ambagts MHC, Rafiee-Tehrani M, Borchard G, Junginger HE (2002) Peroral delivery systems based on superporous hydrogel polymers: release characteristics for the peptide drugs buserelin, octreotide and insulin. Eur J Pharm Sci 15(5):433–439. doi:10.​1016/​S0928-0987(02)00028-3 CrossRef
21.
go back to reference Dorkoosh FA, Verhoef JC, Verheijden JHM, Rafiee-Tehrani M, Borchard G, Junginger HE (2002) Peroral absorption of octreotide in pigs formulated in delivery systems on the basis of superporous hydrogel polymers. Pharm Res 19(10):1532–1536. doi:10.1023/A:1020416918624 CrossRef Dorkoosh FA, Verhoef JC, Verheijden JHM, Rafiee-Tehrani M, Borchard G, Junginger HE (2002) Peroral absorption of octreotide in pigs formulated in delivery systems on the basis of superporous hydrogel polymers. Pharm Res 19(10):1532–1536. doi:10.​1023/​A:​1020416918624 CrossRef
22.
go back to reference Pan Y, Li Y-j, Zhao H-y, Zheng J-m, Xu H, Wei G et al (2002) Bioadhesive polysaccharide in protein delivery system chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int J Pharm 249:139–147 Pan Y, Li Y-j, Zhao H-y, Zheng J-m, Xu H, Wei G et al (2002) Bioadhesive polysaccharide in protein delivery system chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int J Pharm 249:139–147
23.
go back to reference Sung H-W, Lin Y-H, Tu H, inventors; GP Medical, Inc., assignee (2007) Nanoparticles for protein drug delivery patent 7291598 Sung H-W, Lin Y-H, Tu H, inventors; GP Medical, Inc., assignee (2007) Nanoparticles for protein drug delivery patent 7291598
24.
go back to reference Hesing-Wen S, Chen M-C, Lin Y-H, Liang H-F, Tu H, inventors; GP Medical, Inc., assignee (2009) Nanoparticles for protein drug delivery patent 7541046 Hesing-Wen S, Chen M-C, Lin Y-H, Liang H-F, Tu H, inventors; GP Medical, Inc., assignee (2009) Nanoparticles for protein drug delivery patent 7541046
25.
go back to reference Sung H-W, Liang H-F, Tu H, inventors; GP Medical, Inc., assignee (2009) Nanoparticles for protein drug delivery patent 7604795 Sung H-W, Liang H-F, Tu H, inventors; GP Medical, Inc., assignee (2009) Nanoparticles for protein drug delivery patent 7604795
26.
go back to reference Woitiski CB, Neufeld RJ, Veiga F, Carvalho RA, Figueiredo IV (2010) Pharmacological effect of orally delivered insulin facilitated by multilayered stable nanoparticles. Eur J Pharm Sci Off J Eur Fed Pharm Sci 41(3–4):556–563. doi:10.1016/j.ejps.2010.08.009 Woitiski CB, Neufeld RJ, Veiga F, Carvalho RA, Figueiredo IV (2010) Pharmacological effect of orally delivered insulin facilitated by multilayered stable nanoparticles. Eur J Pharm Sci Off J Eur Fed Pharm Sci 41(3–4):556–563. doi:10.​1016/​j.​ejps.​2010.​08.​009
27.
go back to reference Avadi MR, Sadeghi AM, Mohammadpour N, Abedin S, Atyabi F, Dinarvand R et al (2010) Preparation and characterization of insulin nanoparticles using chitosan and Arabic gum with ionic gelation method. Nanomedicine: Nanotechnol Biol Med 6(1):58–63. doi:10.1016/j.nano.2009.04.007 Avadi MR, Sadeghi AM, Mohammadpour N, Abedin S, Atyabi F, Dinarvand R et al (2010) Preparation and characterization of insulin nanoparticles using chitosan and Arabic gum with ionic gelation method. Nanomedicine: Nanotechnol Biol Med 6(1):58–63. doi:10.​1016/​j.​nano.​2009.​04.​007
29.
go back to reference Smith J, Wood E, Dornish M (2004) Effect of chitosan on epithelial cell tight junctions. Pharm Res 21(1):43–49CrossRef Smith J, Wood E, Dornish M (2004) Effect of chitosan on epithelial cell tight junctions. Pharm Res 21(1):43–49CrossRef
31.
go back to reference Chalasani KB, Russell-Jones GJ, Jain AK, Diwan PV, Jain SK (2007) Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles. J Control Release Off J Control Release Soc 122(2):141–150. doi:10.1016/j.jconrel.2007.05.019 CrossRef Chalasani KB, Russell-Jones GJ, Jain AK, Diwan PV, Jain SK (2007) Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles. J Control Release Off J Control Release Soc 122(2):141–150. doi:10.​1016/​j.​jconrel.​2007.​05.​019 CrossRef
32.
33.
go back to reference Russell-Jones GJ, McEwan JF, inventors; Biotech Australia Pty Limited, assignee (2000) Vitamin12 derivatives and methods for their preparation. Australia patent 6150341 Russell-Jones GJ, McEwan JF, inventors; Biotech Australia Pty Limited, assignee (2000) Vitamin12 derivatives and methods for their preparation. Australia patent 6150341
34.
go back to reference Kurita K, Ikeda H, Yoshida Y, Shimojoh M, Harata M (2002) Chemoselective protection of the amino groups of chitosan by controlled phthaloylation: facile preparation of a precursor useful for chemical modifications. Biomacromolecules 3(1):1–4CrossRef Kurita K, Ikeda H, Yoshida Y, Shimojoh M, Harata M (2002) Chemoselective protection of the amino groups of chitosan by controlled phthaloylation: facile preparation of a precursor useful for chemical modifications. Biomacromolecules 3(1):1–4CrossRef
35.
go back to reference Sahu SK, Mallick SK, Santra S, Maiti TK, Ghosh SK, Pramanik P (2010) In vitro evaluation of folic acid modified carboxymethyl chitosan nanoparticles loaded with doxorubicin for targeted delivery. J Mater Sci Mater Med 21(5):1587–1597. doi:10.1007/s10856-010-3998-4 Sahu SK, Mallick SK, Santra S, Maiti TK, Ghosh SK, Pramanik P (2010) In vitro evaluation of folic acid modified carboxymethyl chitosan nanoparticles loaded with doxorubicin for targeted delivery. J Mater Sci Mater Med 21(5):1587–1597. doi:10.​1007/​s10856-010-3998-4
36.
go back to reference Sieval AB, Thanou M, Kotzk AF, Verhoef JC, Brussee J, Junginger HE (1998) Preparation and NMR characterization of highly substituted N-trimethyl chitosan chloride.pdf. Carbohydr Polym 36:157–165CrossRef Sieval AB, Thanou M, Kotzk AF, Verhoef JC, Brussee J, Junginger HE (1998) Preparation and NMR characterization of highly substituted N-trimethyl chitosan chloride.pdf. Carbohydr Polym 36:157–165CrossRef
37.
go back to reference Li S-Q, Zhou P-J, Yao P-J, Wei Y-A, Zhang Y-H, Yue W (2010) Preparation of O-carboxymethyl-N-trimethyl chitosan chloride and flocculation of the wastewater in sugar refinery. J Appl Polym Sci. doi:10.1002/app.31899 Li S-Q, Zhou P-J, Yao P-J, Wei Y-A, Zhang Y-H, Yue W (2010) Preparation of O-carboxymethyl-N-trimethyl chitosan chloride and flocculation of the wastewater in sugar refinery. J Appl Polym Sci. doi:10.​1002/​app.​31899
38.
go back to reference Dash S, Murthy PN, Nath L, Chowdhury P (2010) Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm-Drug Res 67(3):217–223 Dash S, Murthy PN, Nath L, Chowdhury P (2010) Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm-Drug Res 67(3):217–223
39.
go back to reference Higuchi T, Connors KA (1965) Phase-solubility techniques. Adv Anal Chem Instrum 4:117–122 Higuchi T, Connors KA (1965) Phase-solubility techniques. Adv Anal Chem Instrum 4:117–122
40.
go back to reference Korsmyer RW, Gumy R, Doelker E, Buri P, Peppas NA (1983) Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 15:25–35 Korsmyer RW, Gumy R, Doelker E, Buri P, Peppas NA (1983) Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 15:25–35
41.
go back to reference Kadajji VG, Betageri GV (2011) Water soluble polymers for pharmaceutical applications. Polymers 3(4):1972–2009CrossRef Kadajji VG, Betageri GV (2011) Water soluble polymers for pharmaceutical applications. Polymers 3(4):1972–2009CrossRef
42.
go back to reference Saarinen-Savolainen P, Järvinen T, Taipale H, Urtti A (1997) Method for evaluating drug release from liposomes in sink conditions. Int J Pharm 159(1):27–33 Saarinen-Savolainen P, Järvinen T, Taipale H, Urtti A (1997) Method for evaluating drug release from liposomes in sink conditions. Int J Pharm 159(1):27–33
43.
go back to reference El-Leithy ES, Shaker DS, Ghorab MK, Abdel-Rashid RS (2010) Optimization and characterization of diclofenac sodium microspheres prepared by a modified coacervation method. Drug Discov Ther 4(3):208–216 El-Leithy ES, Shaker DS, Ghorab MK, Abdel-Rashid RS (2010) Optimization and characterization of diclofenac sodium microspheres prepared by a modified coacervation method. Drug Discov Ther 4(3):208–216
Metadata
Title
Preparation and characterization of novel derivatives of chitosan and trimethyl chitosan conjugated with dipeptides and vitamin B12 as candidates for oral delivery of insulin
Authors
Nersi Jafary Omid
Niloofar Babanejad
Hossein Amini
Mohsen Amini
Morteza Rafiee Tehrani
Farid Dorkoosh
Publication date
01-08-2014
Publisher
Springer Netherlands
Published in
Journal of Polymer Research / Issue 8/2014
Print ISSN: 1022-9760
Electronic ISSN: 1572-8935
DOI
https://doi.org/10.1007/s10965-014-0510-8

Other articles of this Issue 8/2014

Journal of Polymer Research 8/2014 Go to the issue

Premium Partners